"Novel Drug Significantly Reduces Children's Allergic Reactions to Multiple Food Traces"
A drug called Xolair has been found to significantly reduce the risk of life-threatening reactions in children with severe food allergies when exposed to trace amounts of allergens such as peanuts, cashews, milk, and eggs. The drug, already approved by the FDA for adults and children over age 1 with food allergies, is the first treatment to drastically cut the risk of serious reactions, like anaphylaxis, after accidental exposures to various food allergens. The study's results were presented at the annual conference of the American Academy of Allergy, Asthma and Immunology and published in The New England Journal of Medicine, offering hope for children with severe food allergies.
- Drug Drastically Reduces Children's Reactions to Traces of Food Allergens The New York Times
- Xolair for food allergies: How it works and what it costs NBC News
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial National Institutes of Health (NIH) (.gov)
- The Asthma Drug Xolair Can Drastically Reduce Food Allergies | TIME TIME
- Hopkins researchers help with study of food allergy drug Baltimore Sun
Reading Insights
0
1
1 min
vs 2 min read
70%
359 → 108 words
Want the full story? Read the original article
Read on The New York Times